Zydus Cadila to manufacture ‘COVID KAVACH ELISA’

11 May 2020 Evaluate

Zydus Cadila is going to manufacture ‘COVID KAVACH ELISA’ - the first indigenously developed IgG ELISA test for antibody detection by the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune.

With diagnostic kits for testing COVID 19 being the need of the hour, Zydus Cadila welcomes the development of indigenous IgG ELISA test for antibody detection by the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV) at Pune. The kits will be manufactured through a tech transfer by Cadila Healthcare, at Moraiya Ahmedabad.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

997.45 12.70 (1.29%)
15-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1528.20
Dr. Reddys Lab 5872.35
Cipla 1405.95
Zydus Lifesciences 997.45
Lupin 1638.40
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.